Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.
Nakagawa, Tohru
Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up. [electronic resource] - Experimental hematology Jul 2004 - 599-606 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0301-472X
10.1016/j.exphem.2004.04.006 doi
Acute Disease
Adult
Carcinoma, Renal Cell--pathology
Chronic Disease
Female
Follow-Up Studies
Graft vs Host Disease--epidemiology
Histocompatibility Testing
Humans
Kidney Neoplasms--pathology
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Staging
Nephrectomy
Patient Selection
Retrospective Studies
Stem Cell Transplantation--adverse effects
Survival Analysis
Time Factors
Transplantation Conditioning--methods
Transplantation, Homologous--adverse effects
Treatment Outcome
Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up. [electronic resource] - Experimental hematology Jul 2004 - 599-606 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0301-472X
10.1016/j.exphem.2004.04.006 doi
Acute Disease
Adult
Carcinoma, Renal Cell--pathology
Chronic Disease
Female
Follow-Up Studies
Graft vs Host Disease--epidemiology
Histocompatibility Testing
Humans
Kidney Neoplasms--pathology
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Staging
Nephrectomy
Patient Selection
Retrospective Studies
Stem Cell Transplantation--adverse effects
Survival Analysis
Time Factors
Transplantation Conditioning--methods
Transplantation, Homologous--adverse effects
Treatment Outcome